Moisand Fitzgerald Tamayo, LLC Agios Pharmaceuticals, Inc. Transaction History

Moisand Fitzgerald Tamayo, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 11, 2019	SELL	$42.73 - $76.53 $2.06 Million - $3.69 Million	-48,182 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$71.67 - $91.95 $3.45 Million - $4.43 Million	48,182 New	48,182 $48,000
Q2 2018 Aug 08, 2018	SELL	$73.22 - $99.55 $3.27 Million - $4.45 Million	-44,709 Closed	0 $0
Q1 2018 Apr 30, 2018	BUY	$59.83 - $86.53 $75,146 - $108,681	1,256 Added 2.89%	44,709 $45,000
Q4 2017 Jan 23, 2018	BUY	$52.12 - $72.33 $87,040 - $120,791	1,670 Added 4.0%	43,453 $43,000
Q3 2017 Nov 03, 2017	BUY	$54.89 - $67.12 $92,050 - $112,560	1,677 Added 4.18%	41,783 $42,000
Q2 2017 Aug 08, 2017	BUY	N/A	40,106	40,106 $40,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.05B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Moisand Fitzgerald Tamayo, LLC, based on Form 13F filings with the SEC.

Stay updated on Moisand Fitzgerald Tamayo, LLC with notifications on news.